Concepedia

Homayoun Roshanisefat

HR

Statistics

Publications

9

Citations

1.5K

H-Index

9

Active since

2012

Affiliations

Danish Multiple Sclerosis Center(Current)

Karolinska University Hospital

Karolinska Institutet

Aarhus University Hospital

Homayoun Roshanisefat is an author at Danish Multiple Sclerosis Center specializing in multiple sclerosis, medicine, and multiple sclerosis therapy.

Publications per year

2012–2023

9

Publications

9

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Multiple sclerosis clinical course and cardiovascular disease risk – <scp>S</scp>wedish cohort study

Homayoun Roshanisefat, Shahram Bahmanyar, Jan Hillert et al. · European Journal of Neurology · 2014 · 75 citations

Public Health, Chronic Disease Prevention, Clinical Epidemiology +13

Comparative effectiveness of teriflunomide and dimethyl fumarate

Mathias Due Buron, Thor Ameri Chalmer, Finn Sellebjerg et al. · Neurology · 2019 · 45 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis

Homayoun Roshanisefat, Shahram Bahmanyar, Jan Hillert et al. · Multiple Sclerosis Journal · 2012 · 39 citations

Life Sciences, Genetics, Immunology +17

1–5 of 9